4//SEC Filing
Marks Gilbert Lynn 4
Accession 0000950170-25-077036
CIK 0001880438other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:51 PM ET
Size
5.1 KB
Accession
0000950170-25-077036
Insider Transaction Report
Form 4
Marks Gilbert Lynn
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-22+19,111→ 19,111 totalExercise: $1.19Exp: 2035-05-21→ Common Stock (19,111 underlying)
Footnotes (1)
- [F1]The option shares shall vest on March 31, 2026, subject to the Reporting Person providing continuous service through such date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001916940
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:51 PM ET
- Size
- 5.1 KB